Patents by Inventor Michael Harre

Michael Harre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230205899
    Abstract: Using a computer system, an instruction is received to define or modify a permission constraint corresponding to one or more files. A permission-instruction data set representing the permission constraint is stored in a data store. Subsequent to storing the permission-instruction data, a user request to access a particular file is intercepted. The data store is queried to determine whether any pending permission-instruction data set corresponds to the particular file. In response to the query, it is determined that the permission-instruction data set corresponds to the particular file. A permission constraint of the particular file is added or modified based on the permission-instruction data set. Based on the modified or added permission constraint, it is determined whether and/or an extent to which the user request is authorized. A response to the user request based on the determination as to whether and/or an extent to which the user request is authorized.
    Type: Application
    Filed: January 5, 2022
    Publication date: June 29, 2023
    Applicant: Oracle International Corporation
    Inventors: John Michael Harres, Darren James Moffat, Mark Leroy Shellenbaum
  • Publication number: 20230205900
    Abstract: An instruction is received to define or modify a permission constraint corresponding to one or more file. A period of time is determined, where the period is one during which the defined or modified permission constraint is to apply to the one or more files. It is determined that the one or more files are to be deleted following completion of the period of time. A permission-instruction data set representing the permission constraint and a flag indicating that the one or more files are to be deleted following completion of the period of time are stored in a data store. It is detected that the period of time has ended. The one or more files are deleted in response to the detection.
    Type: Application
    Filed: September 12, 2022
    Publication date: June 29, 2023
    Applicant: Oracle International Corporation
    Inventors: John Michael Harres, Darren James Moffat, Mark Leroy Shellenbaum
  • Publication number: 20230205903
    Abstract: Using a computer system, an instruction is received to define or modify a permission constraint corresponding to one or more files. A permission-instruction data set representing the permission constraint is stored in a data store. Subsequent to storing the permission-instruction data, a user request to access a particular file is intercepted. The data store is queried to determine whether any pending permission-instruction data set corresponds to the particular file. In response to the query, it is determined that the permission-instruction data set corresponds to the particular file. A permission constraint of the particular file is added or modified based on the permission-instruction data set. Based on the modified or added permission constraint, it is determined whether and/or an extent to which the user request is authorized. A response to the user request based on the determination as to whether and/or an extent to which the user request is authorized.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 29, 2023
    Applicant: Oracle International Corporation
    Inventors: John Michael Harres, Darren James Moffat, Mark Leroy Shellenbaum
  • Patent number: 9000037
    Abstract: This invention relates to novel precursors suitable for 18F radiolabeling of glutamate derivatives, methods for preparing such compounds and its intermediates, compositions comprising such compounds, kits comprising such compounds or compositions and methods for 18F radiolabeling of glutamate derivatives wherein the obtained 18F radiolabeled glutamate derivatives are suitable for diagnostic imaging by Positron Emission Tomography (PET) of proliferative diseases e.g. tumor in mammals.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: April 7, 2015
    Assignee: Piramal Imaging SA
    Inventors: Christina Hultsch, Michael Harre, Filip Novak, Mathias Berndt, Matthias Friebe, Heribert Schmitt-Willich, Dae Yoon Chi, Byoung Se Lee, Sang Don Park
  • Publication number: 20140243532
    Abstract: This invention relates to novel precursors suitable for 18F radiolabeling of glutamate derivatives, methods for preparing such compounds and its intermediates, compositions comprising such compounds, kits comprising such compounds or compositions and methods for 18F radiolabeling of glutamate derivatives wherein the obtained 18F radiolabeled glutamate derivatives are suitable for diagnostic imaging by Positron Emission Tomography (PET) of proliferative diseases e.g. tumor in mammals.
    Type: Application
    Filed: April 30, 2012
    Publication date: August 28, 2014
    Applicant: PIRAMAL IMAGING SA
    Inventors: Christina Hultsch, Michael Harre, Filip Novak, Mathias Berndt, Matthias Friebe, Heribert Schmitt-Willich, Dae Yoon Chi, Byoung Se Lee, Sang Don Park
  • Patent number: 8420831
    Abstract: The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-fluoro-4-thio-?-D-arabinofuranoses having formula I and intermediates thereof: wherein R1 represents —C(O)—C1-C6-alkyl or —C(O)-aryl; and R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: April 16, 2013
    Assignee: LIBRAMEDICINA, Inc.
    Inventors: David Voigtländer, Michael Sander, Michael Harre
  • Publication number: 20130005991
    Abstract: The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-fluoro-4-thio-?-D-arabinofuranoses having formula I and intermediates thereof: wherein R1 represents —C(O)—C1-C6-alkyl or —C(O)-aryl; and R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl.
    Type: Application
    Filed: September 7, 2012
    Publication date: January 3, 2013
    Applicant: LibraMedicina, Inc.
    Inventors: David VOIGTLÄNDER, Michael SANDER, Michael HARRE
  • Patent number: 8329925
    Abstract: The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-fluoro-4-thio-?-D-arabinofuranoses having formula I and intermediates thereof: wherein R1 represents —C(O)—C1-C6-alkyl or —C(O)-aryl; and R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: December 11, 2012
    Assignee: Libramedicina, Inc.
    Inventors: David Voigtländer, Michael Sander, Michael Harre
  • Publication number: 20110152542
    Abstract: The present invention relates to a process for preparing 1-O-acyl-2-deoxy-2-fluoro-4-thio-?-D-arabinofuranoses having formula I and intermediates thereof: wherein R1 represents —C(O)—C1-C6-alkyl or —C(O)-aryl; and R2 represents C1-C6-alkyl, C1-C4-perfluoroalkyl or aryl.
    Type: Application
    Filed: December 3, 2010
    Publication date: June 23, 2011
    Inventors: David Voigtländer, Michael Sander, Michael Harre
  • Patent number: 5391778
    Abstract: The new intermediate products of general formula I ##STR1## in which R.sup.1 stands for a hydrogen atom or a straight-chain or branched alkyl group with 1 to 4 carbon atoms,R.sup.2 stands for a hydrogen atom or a methyl group,R.sup.3 stands for a hydrogen atom,R.sup.4 stands for an acyloxy group with 1 to 4 carbon atoms in the acyl radical orR.sup.3 and R.sup.4 together stand for a keto-oxygen atom, are suitable in an excellent way for introducing a .DELTA..sup.1 double bond in the steroid skelton with the simultaneous presence of a .DELTA..sup.4 double bond, as well as a saturated carbonyl group, by clevage of hydrogen iodide with a base in an amidic solvent at elevated temperature. If R.sup.2 stands for a hydrogen atom, the A-ring is aromatized after the hydrogen iodide cleavage. For the production of a new intermediate products, special iodization processes, which partially also allow a stereoselective control of the iodization, are used.
    Type: Grant
    Filed: January 11, 1993
    Date of Patent: February 21, 1995
    Assignee: Schering Aktiengesellschaft
    Inventors: Jurgen Westermann, Klaus Nickisch, Michael Harre, Ralph Rohde
  • Patent number: 5288878
    Abstract: The invention concerns a process for preparing (1S,2S,3R,5R)-2-[(3S)-2-halo-3-hydroxy-1-alken(ynyl)]-3-trialkylsilyloxy-7 ,7-(2,2-dimethyltrimethylenedioxy)-bicyclo[3.3.0]octane compounds of general Formula I ##STR1## wherein X is chlorine or bromine,R.sub.1 can mean straight-chain or branched alkyl of up to 6 carbon atoms, straight-chain or branched alkenyl of up to 6 carbon atoms, straight-chain or branched alkynyl of up to 6 carbon atoms,R.sub.2, R.sub.3, R.sub.4 can be in each case identical or different and can mean C.sub.1 -C.sub.4 -alkyl and phenyl optionally substituted by C.sub.1 -C.sub.4 -alkyl groups, wherein the 13,14-double bond has the trans configuration with respect to the C chain, by stereoselective reduction of an .alpha.-halo-enone of general Formula II ##STR2## wherein X, R.sub.1, R.sub.2, R.sub.3, R.sub.4 have the meanings given above,with a reagent produced from diisobutyl aluminum hydride and 2,6-di-tert-butyl-4-methylphenol.
    Type: Grant
    Filed: June 12, 1991
    Date of Patent: February 22, 1994
    Assignee: Schering Aktiengesellschaft
    Inventors: Michael Harre, Jurgen Westermann
  • Patent number: 4709077
    Abstract: Novel 7-(Aryloxy)-2-naphthoxyalkanecarboxylic acid derivatives of the formula I ##STR1## in racemic or separated isomeric form, have herbicidal activity.
    Type: Grant
    Filed: September 17, 1985
    Date of Patent: November 24, 1987
    Assignee: Schering Aktiengesellschaft
    Inventors: Michael Harre, Hans-Rudolf Kruger, Friedrich Arndt, Reinhart Rusch